Some MDS patients harbor del(5q), with haploinsufficiency for a set of genes including HSPA9. We showed that inhibition of HSPA9 disrupts erythroid maturation in human CD34+ hematopoietic progenitor cells, through a TP53-dependent mechanism. The gene discussed is HSPA9; the disease is myelodysplastic syndrome.